Literature DB >> 9107624

Acute effects of treadmill running on lipoprotein(a) levels in males and females.

L Hubinger1, L T Mackinnon, L Barber, J McCosker, A Howard, F Lepre.   

Abstract

This investigation examined the acute response of serum lipoprotein(a) (Lp(a)) concentration immediately after, and during several days following, level and downhill motorized treadmill running. Eight males ran for 1 h on a level motorized treadmill at an intensity producing 90% maximum heart rate (MHR). On a separate occasion, three males and three females performed downhill (negative 13.4% incline) treadmill running at an intensity producing 75-80% MHR. For both protocols, serial blood samples were taken pre- and post-exercise and at the same time of day 1, 3, 5, and 7 days following exercise. Levels of Lp(a), creatine kinase (CK), C-reactive protein (CRP), and ferritin were measured. Repeated measures statistical analysis (Friedman ANOVA) showed no significant change in the median level of Lp(a) (level run, 5.0 mg.dl-1; downhill run, 7.45 mg.dl-1) across time following either protocol. After level running, ferritin levels 5 and 7 d post-exercise were significantly (P < 0.05) lower compared with immediately and 1 d post-exercise measures (Friedman ANOVA). Following level running, the Wilcoxon signed rank test showed significant (P < 0.05) elevations in CK levels immediately, 1 and 5 d post-exercise compared with pre-exercise values. Following downhill running. CK level was significantly elevated up to 3 d post-exercise (Wilcoxon signed rank). Calculated plasma volume did not change significantly following either protocol. These data suggest that Lp(a) does not change acutely in response to level or downhill treadmill running up to 60 min duration.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9107624     DOI: 10.1097/00005768-199704000-00003

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  8 in total

1.  Does smoking status influence the effect of physical exercise on fibrinolytic function in healthy volunteers?

Authors:  Antonio Tello-Montoliu; Vanessa Roldán; Vicente E Climent; Francisco Sogorb; Gregory Y H Lip; Francisco Marín
Journal:  J Thromb Thrombolysis       Date:  2006-04       Impact factor: 2.300

Review 2.  Fatigue associated with prolonged graded running.

Authors:  Marlene Giandolini; Gianluca Vernillo; Pierre Samozino; Nicolas Horvais; W Brent Edwards; Jean-Benoît Morin; Guillaume Y Millet
Journal:  Eur J Appl Physiol       Date:  2016-07-25       Impact factor: 3.078

3.  Lipoprotein (a) does not participate in the early acute phase response to training or extreme physical activity and is unlikely to enhance any associated immediate cardiovascular risk.

Authors:  D J Byrne; I A Jagroop; H E Montgomery; M Thomas; D P Mikhailidis; N G Milton; A F Winder
Journal:  J Clin Pathol       Date:  2002-04       Impact factor: 3.411

Review 4.  Exercise: an important component of treatment in the idiopathic inflammatory myopathies.

Authors:  Helene Alexanderson
Journal:  Curr Rheumatol Rep       Date:  2005-04       Impact factor: 4.592

Review 5.  Effects of exercise on lipoprotein(a).

Authors:  L T Mackinnon; L M Hubinger
Journal:  Sports Med       Date:  1999-07       Impact factor: 11.136

6.  Associations of Low-Intensity Resistance Training with Body Composition and Lipid Profile in Obese Patients with Type 2 Diabetes.

Authors:  Hidetaka Hamasaki; Yu Kawashima; Yoshiki Tamada; Masashi Furuta; Hisayuki Katsuyama; Akahito Sako; Hidekatsu Yanai
Journal:  PLoS One       Date:  2015-07-15       Impact factor: 3.240

Review 7.  Downhill Running: What Are The Effects and How Can We Adapt? A Narrative Review.

Authors:  Bastien Bontemps; Fabrice Vercruyssen; Mathieu Gruet; Julien Louis
Journal:  Sports Med       Date:  2020-12       Impact factor: 11.136

Review 8.  Non-genetic influences on lipoprotein(a) concentrations.

Authors:  Byambaa Enkhmaa; Lars Berglund
Journal:  Atherosclerosis       Date:  2022-05       Impact factor: 6.847

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.